Status:
COMPLETED
Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer
Lead Sponsor:
San Jose State University
Conditions:
Breast Neoplasms
Survivorship
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this randomized controlled trial is to evaluate the effectiveness of an empirically supported psychosocial treatment, Acceptance and Commitment Therapy, in facilitating improved quality...
Detailed Description
Previous research indicates that breast cancer patients may demonstrate disrupted diurnal cortisol rhythms compared to healthy individuals, and that these disrupted rhythms may be related to recurrenc...
Eligibility Criteria
Inclusion
- diagnosis of stage I-III breast cancer
- prescreen distress score above defined cutoff
- agreement not to seek other breast cancer support services until study completion
Exclusion
- previous cancer
- prior psychiatric treatment for serious mental health disorder (e.g., hospitalization or formal diagnosis of psychosis, major depressive episode, borderline mental retardation, suicidality, or current substance dependence)
- current use of medications known to interfere with cortisol levels (e.g., dexamethasone)
- major concurrent medical disease
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01164930
Start Date
January 1 2010
End Date
September 1 2011
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Jose State University
San Jose, California, United States, 95192